Brokerages Set Vor Biopharma Inc. (NYSE:VOR) PT at $8.86
Vor Biopharma Inc. (NYSE:VOR – Get Free Report) has received a consensus recommendation of “Buy” from the seven analysts that are currently covering the firm, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have issued a report on the stock […]
Vor Biopharma Inc. (NYSE:VOR – Get Free Report) has received a consensus recommendation of “Buy” from the seven analysts that are currently covering the firm, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have issued a report on the stock […]